ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,872Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 609

$800K Total Retail Price of All Prescriptions

Rank: 45 out of 609

358 Patients Receiving at Least One Drug in Part D
45%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

44% of this provider’s 358 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 6,160 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 36%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $117 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
ENDOCET 590 164 S2 1 45
OXYCODONE HCL 373 119 S2 2 23
NEXIUM 345 176 3 13
SIMVASTATIN 336 209 4 1
AMLODIPINE BESYLATE 324 223 5 2
NAPROXEN 283 135 6 98
ZOLPIDEM TARTRATE 282 130 7 18
CRESTOR 252 152 8 16
METFORMIN HCL 236 168 9 10
ATORVASTATIN CALCIUM 227 130 10 6
FUROSEMIDE 198 167 11 4
AZITHROMYCIN 197 72 12 67
PROAIR HFA 196 81 13 57
TIZANIDINE HCL 196 74 13 189
OMEPRAZOLE 178 114 15 3
LEVOTHYROXINE SODIUM 168 111 16 7
LOVAZA 163 78 17 73
LISINOPRIL 143 107 18 12
CIPROFLOXACIN HCL 140 59 19 42
TAMSULOSIN HCL 140 108 19 11
CLOTRIMAZOLE-BETAMETHASONE 138 39 21 135
DIVALPROEX SODIUM 131 77 22 101
OXYCODONE HCL-ACETAMINOPHEN 126 48 S2 23 72
OXYCONTIN 124 41 S2 24 64
ATENOLOL 124 102 24 27
PROMETHAZINE HCL 115 27 R 26 311
RAMIPRIL 115 66 26 46
TRIAMTERENE-HCTZ 114 72 28 204
MUPIROCIN 108 64 29 180
CLOPIDOGREL 104 65 30 17
TRAMADOL HCL 103 70 31 39
BENZTROPINE MESYLATE 102 44 R 32 207
METOPROLOL TARTRATE 98 82 33 9
CLONIDINE HCL 95 38 34 83
CELEBREX 92 47 35 60
FAMOTIDINE 86 39 36 50
GLYBURIDE-METFORMIN HCL 79 34 R 37 149
VOLTAREN 76 53 38 159
ADVAIR DISKUS 75 25 39 28
RISPERIDONE 75 49 39 107
TRAMADOL HCL-ACETAMINOPHEN 74 16 41 102
WARFARIN SODIUM 72 70 42 8
DIOVAN HCT 72 49 42 31
GLIMEPIRIDE 72 41 42 53
PLAVIX 70 44 45 25
SPIRIVA 68 30 46 43
ABILIFY 66 50 47 161
HALOPERIDOL 66 37 47 309
AMOX TR-POTASSIUM CLAVULANATE 66 22 47 249
CLOZAPINE 65 0 50 296
SERTRALINE HCL 64 22 51 61
DIOVAN 64 40 51 15
CYCLOBENZAPRINE HCL 63 0 R 53 95
HYDROXYZINE HCL 61 25 R 54 290
LITHIUM CARBONATE 60 0 55 336
GLYBURIDE 59 42 R 56 132
ENALAPRIL MALEATE 57 38 57 32
JANUVIA 57 44 57 34
BYSTOLIC 55 26 59 71
FOSINOPRIL SODIUM 55 27 59 464
HYDROCHLOROTHIAZIDE 53 32 61 20
IBUPROFEN 51 13 62 103
VERAPAMIL ER 51 51 62 168
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.